Michael Benkowitz

2021

In 2021, Michael Benkowitz earned a total compensation of $2.3M as President and Chief Operating Officer at United Therapeutics, a 55% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$355,353
Non-Equity Incentive Plan$1,004,063
Salary$940,385
Other$16,691
Total$2,316,492

Benkowitz received $1M in non-equity incentive plan, accounting for 43% of the total pay in 2021.

Benkowitz also received $355.4K of change in pension value and nonqualified deferred compensation earnings, $940.4K in salary and $16.7K in other compensation.

Rankings

In 2021, Michael Benkowitz's compensation ranked 5,451st out of 12,415 executives tracked by ExecPay. In other words, Benkowitz earned more than 56.1% of executives.

ClassificationRankingPercentile
All
5,451
out of 12,415
56th
Division
Manufacturing
2,300
out of 5,505
58th
Major group
Chemicals And Allied Products
1,001
out of 2,375
58th
Industry group
Drugs
891
out of 2,096
58th
Industry
Pharmaceutical Preparations
640
out of 1,546
59th

Pay ratio

Michael Benkowitz's Pay$2,316,492
Median Employee's Pay$189,023
Pay Ratio

12

to 1

In 2021, the annual total compensation of Michael Benkowitz was $2,316,492.

The annual total compensation of the median employee at United Therapeutics was $189,023.

The ratio of Michael Benkowitz's pay to the pay of median employee was therefore 12 to one.

Source: SEC filing on April 29, 2022.

Benkowitz's colleagues

We found three more compensation records of executives who worked with Michael Benkowitz at United Therapeutics in 2021.

2021

Martine Rothblatt

United Therapeutics

Chief Executive Officer

2021

James Edgemond

United Therapeutics

Chief Financial Officer

2021

Paul Mahon

United Therapeutics

General Counsel

News

You may also like